Report 04-2017
It is hard to reconcile the fundamentals of economies with stock market quotes.
Timid correction of the indexes served only to cool the excesses, but the first quarter of the major US corporations, and not only, brought new lymph to the rise of indices.
In particular, High Tech's big companies, which reported well above expectations, led the Nasdaq toward a new maximum.
The strategy adopted for our portfolio, we can summarize it in:
- maintaining high weight for Biotech and Pharma titles;
- overweight technology and banking securities.
We attach schedule of the portfolio.
Giorgio Giovannoni
 Report 04-2017.pdf | [ ] | 164 kB |
